A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib
for Hepatic Impairment
Sites in Lake Forest +3 more locations
Sponsor: Genentech, Inc.
Sex: All·Age: 18 - 80·Accepts healthy volunteers
Code: NCT07144111·Phase 1·Recruiting·Listed Aug 2025